EP3790877
Tetrahýdró-imídasó[4,5-c]pýridín-afleiður sem PD-L1 ónæmisstillar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.5.2019EP published:
1.3.2023EP application number:
19725627.4
EP translation filed:
8.5.2023Grant published:
15.6.2023EPO information:
European Patent Register
Max expiry date:
9.5.2039Expiry date:
9.5.2026Next due date:
31.5.2026
Title in English:
TETRAHYDRO-IMIDAZO[4,5-C]PYRIDINE DERIVATIVES AS PD-L1 IMMUNOMODULATORSLanguage of the patent:
English
Timeline
Today
10.5.2019EP application
1.3.2023EP Publication
8.5.2023Translation submitted
15.6.2023Registration published
9.5.2026Expires
Owner
Name:
Incyte CorporationAddress:
1801 Augustine Cut-Off, Wilmington, DE 19803, US
Inventor
Name:
WU, LiangxingAddress:
Wilmington, Delaware 19803, US
Name:
XIAO, KaijiongAddress:
Wilmington, Delaware 19803, US
Name:
YAO, WenqingAddress:
Wilmington, Delaware 19803, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862670249 PDate:
11.5.2018Country:
US
Number:
201862688164 PDate:
21.6.2018Country:
US
Classification
Categories:
C07D 471/04, A61P 35/00, A61P 37/00, A61K 31/437
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 22.4.2023
Expires: 9.5.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 7.5.2024
Expires: 9.5.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 16.5.2025
Expires: 9.5.2026
Payer: Árnason Faktor ehf.